Given the rapid spread of COVID-19, the need to accurately document and diagnose cases of the novel coronavirus is critical to patients, their communities, and the healthcare professionals who serve them. As the response to COVID-19 continues to evolve, there is also a growing need to efficiently monitor and manage those who receive the vaccine. While we wish IMO’s expertise was not needed, this global pandemic is a unique opportunity to support our partner providers around the world in ways that only IMO can.
IMO Precision COVID-19 Sets includes value sets that can be used to identify and analyze patients with COVID-19 problems, diagnoses, and labs to assist with infection control measures and population health protocols. As of January 2021, new value sets have been released to help address prioritization needs related to COVID-19 vaccination, as well as long-term risks stemming from the virus.
IMO Precision COVID-19 Sets is available to all customers, completely free of charge, helping you to:
- Leverage health information systems to identify and monitor patients who have documented COVID-19 problems, diagnoses, and lab test results
- Accelerate vaccine distribution strategies by accurately identifying patients that may be at higher risk of complications from COVID-19
- Analyze the effectiveness of your institution’s COVID-19 management protocol
Please reach out with questions: Call us at